In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.
from Moneycontrol Business News https://ift.tt/2niYPBw
In this website you will get all the news regarding about market of various countries and what to be the next prediction or status of market.
Subscribe to:
Post Comments (Atom)
Best Agrolife acquires 100% stake in Sudarshan Farm Chemicals for Rs 139 crore
The acquisition will enable BAL to leverage SFCL#39;s proficiency in developing cost-effective and distinctive manufacturing routes for off...
-
By BY BEN HUBBARD AND AURELIEN BREEDEN from NYT World https://ift.tt/3oyLkdW >
-
By STEPHANIE SAUL from NYT U.S. https://nyti.ms/2WdcYAk >
No comments:
Post a Comment